IL316583A - Seraphin Peptide History and Methods of Using Them - Google Patents
Seraphin Peptide History and Methods of Using ThemInfo
- Publication number
- IL316583A IL316583A IL316583A IL31658324A IL316583A IL 316583 A IL316583 A IL 316583A IL 316583 A IL316583 A IL 316583A IL 31658324 A IL31658324 A IL 31658324A IL 316583 A IL316583 A IL 316583A
- Authority
- IL
- Israel
- Prior art keywords
- methods
- same
- peptide derivatives
- serpin peptide
- serpin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8121—Serpins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263363840P | 2022-04-29 | 2022-04-29 | |
| PCT/US2023/066321 WO2023212661A1 (en) | 2022-04-29 | 2023-04-27 | Serpin peptide derivatives and methods of using the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL316583A true IL316583A (en) | 2024-12-01 |
Family
ID=88519894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL316583A IL316583A (en) | 2022-04-29 | 2023-04-27 | Seraphin Peptide History and Methods of Using Them |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250353898A1 (https=) |
| EP (1) | EP4514838A1 (https=) |
| JP (1) | JP2025515349A (https=) |
| CN (1) | CN119497719A (https=) |
| AU (1) | AU2023260921A1 (https=) |
| CA (1) | CA3256966A1 (https=) |
| IL (1) | IL316583A (https=) |
| MX (1) | MX2024013323A (https=) |
| WO (1) | WO2023212661A1 (https=) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5439829A (en) * | 1991-01-30 | 1995-08-08 | Eli Lilly And Company | Immobilization of biologically active molecules by changing the Oxidation state of a chelated transition metal ion |
| GB0916578D0 (en) * | 2009-09-22 | 2009-10-28 | Malmsten Nils M | Polypeptides and uses thereof |
| CN102731626B (zh) * | 2011-04-13 | 2014-10-01 | 中国人民解放军军事医学科学院毒物药物研究所 | 环肽及其医药用途 |
| CA3077804C (en) * | 2012-01-09 | 2023-07-25 | Serpin Pharma, Llc | Peptides and methods of using same |
| WO2013172954A1 (en) * | 2012-05-17 | 2013-11-21 | Ra Pharmaceuticals, Inc | Peptide and peptidomimetic inhibitors |
| WO2016154041A1 (en) * | 2015-03-20 | 2016-09-29 | University Of Florida Research Foundation Incorporated | Serpin reactive center loop peptides and methods of use |
| WO2021219896A1 (en) * | 2020-05-01 | 2021-11-04 | Atlas Biotechnology S.A. | Treatment and/or prevention of a disease or a syndrome related to a virus infection |
| EP4003391A4 (en) * | 2020-07-06 | 2023-02-22 | Serpin Pharma, LLC | PEPTIDES AND METHODS OF USE THEREOF |
-
2023
- 2023-04-27 AU AU2023260921A patent/AU2023260921A1/en active Pending
- 2023-04-27 IL IL316583A patent/IL316583A/en unknown
- 2023-04-27 WO PCT/US2023/066321 patent/WO2023212661A1/en not_active Ceased
- 2023-04-27 JP JP2024563519A patent/JP2025515349A/ja active Pending
- 2023-04-27 US US18/861,168 patent/US20250353898A1/en active Pending
- 2023-04-27 CA CA3256966A patent/CA3256966A1/en active Pending
- 2023-04-27 EP EP23797555.2A patent/EP4514838A1/en active Pending
- 2023-04-27 CN CN202380042370.9A patent/CN119497719A/zh active Pending
-
2024
- 2024-10-28 MX MX2024013323A patent/MX2024013323A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP4514838A1 (en) | 2025-03-05 |
| WO2023212661A1 (en) | 2023-11-02 |
| CN119497719A (zh) | 2025-02-21 |
| US20250353898A1 (en) | 2025-11-20 |
| AU2023260921A1 (en) | 2024-11-07 |
| CA3256966A1 (en) | 2023-11-02 |
| MX2024013323A (es) | 2024-12-06 |
| JP2025515349A (ja) | 2025-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4209494A4 (en) | RING MODIFIED PROLINE SHORT PEPTIDE COMPOUND AND USE THEREOF | |
| IL305834A (en) | Phenalkylamines and methods for their preparation and use | |
| EP4279507A4 (en) | CD73-BINDING PROTEIN AND USE THEREOF | |
| IL312466A (en) | PI3K-alpha inhibitors and methods for their preparation and use | |
| EP4516802A4 (en) | Novel anti-inflammatory peptide and use thereof | |
| IL316583A (en) | Seraphin Peptide History and Methods of Using Them | |
| EP4269428A4 (en) | NEW PEPTIDE AND ITS USE | |
| EP4163288A4 (en) | NEW NUCLEOLIN-BINDING PEPTIDE AND USE THEREOF | |
| HK40121384A (en) | Serpin peptide derivatives and methods of using the same | |
| EP4446335A4 (en) | NEW PEPTIDE AND ITS USE | |
| HK40111751A (en) | Serpin peptides and methods of using the same | |
| IL318460A (en) | RABIES G protein and its uses | |
| AU2021371342A9 (en) | Peptides and methods of use | |
| EP4236982A4 (en) | PEPTIDES AND METHODS OF USE | |
| IL308683A (en) | Peptides and methods of use | |
| EP4203988A4 (en) | PEPTIDE INHIBITORS OF NF-KAPPA B AND THEIR USE IN THE TREATMENT OF COVID-19 AND INFLAMMATORY DISEASES | |
| EP4021906A4 (en) | N-(2-AMINOPHENYL)-PROP-2-ENAMIDE DERIVATIVES, AND THEIR USES IN THE TREATMENT OF CANCER | |
| CA3277627A1 (en) | Peptide and use thereof | |
| IL321653A (en) | Peptide and its use | |
| EP3747871A4 (en) | CRYSTAL FORM OF THE URATTRANSPORTER-1 INHIBITOR AND METHOD FOR ITS MANUFACTURING AND USE | |
| HK40127579A (en) | Peptide-based delivery agent and method of making and using the same | |
| CA3262709A1 (en) | Peptide-based administration agent and its process of manufacture and use | |
| IL318368A (en) | Amofamyl-binding protein inhibitors and their uses | |
| CA3291343A1 (en) | Methanolytic agents and methods of using the same | |
| AU2024272693A1 (en) | Methanolytic agents and methods of using the same |